Pharma MNCs seek relief from price control for patented drugs

The Organisation of Pharmaceutical Producers of India (OPPI) is requesting exemptions for patented and orphan drugs from government price controls. They argue that current regulations hinder innovation and want more control over pricing post-patent expiry to provide economic incentives for inventors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dmMxwFP
via IFTTT